Cheney Drew

914 citations

30 papers · 442 indexed · h-index 13

Impact in

Cellular and Molecular Neuroscience top 10%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
Neurology top 10%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Cellular and Molecular Neuroscience 22
- Genetic Neurodegenerative Diseases 20
- Neuroscience and Neuropharmacology Research 4
Neurology 12
- Neurological disorders and treatments 8
- Parkinson's Disease Mechanisms and Treatments 4
- Neurology and Historical Studies 2

Co-authors: A. Jennifer Morton (4 shared papers)Patrick N. Pallier (1 shared paper)Rhys H. Thomas (4 shared papers)Monica Busse (17 shared papers)Anne Rosser (14 shared papers)Dervila Glynn (1 shared paper)Kerstin Reim (1 shared paper)Nils Brose (1 shared paper)
Journals: Human Molecular Genetics (2 papers)Brain (2 papers)Journal of Neurology Neurosurgery & Psychiatry (2 papers)Physical Therapy (2 papers)BMJ Open (1 paper)
Partner nations: United Kingdom United States Australia

In The Last Decade

Cheney Drew

29 papers receiving 436 citations

Peers

Countries citing papers authored by Cheney Drew

Since Specialization

Citations

This map shows the geographic impact of Cheney Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheney Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheney Drew more than expected).

Fields of papers citing papers by Cheney Drew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheney Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheney Drew. The network helps show where Cheney Drew may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheney Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheney Drew Line = papers co-authored together Cheney Drew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits Human Molecular Genetics ·Dervila Glynn, Cheney Drew, Kerstin Reim, Nils Brose, A. Jennifer Morton	2005	64
2	Genotype-phenotype correlations in hyperekplexia: apnoeas, learning difficulties and speech delay Brain ·Rhys H. Thomas, Seo‐Kyung Chung, S. E. Wood, Thomas D. Cushion, Cheney Drew, Chrissy L. Hammond, Jean-François Vanbellinghen, Jonathan G.L. Mullins, Mark I. Rees	2013	54
3	The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: Influence of non-motor factors on locomotor function Brain Research Bulletin ·Patrick N. Pallier, Cheney Drew, A. Jennifer Morton	2008	51
4	Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal Human Molecular Genetics ·Cheney Drew, Rachel J. Kyd, A. Jennifer Morton	2007	42
5	The societal cost of Huntington's disease: are we underestimating the burden? European Journal of Neurology ·Carys Jones, Monica Busse, Lori Quinn, Helen Dawes, Cheney Drew, Mark Kelson, Kerenza Hood, Anne Rosser, Rhiannon Tudor Edwards	2016	34
6	Physical Activity Self-Management and Coaching Compared to Social Interaction in Huntington Disease: Results From the ENGAGE-HD Randomized, Controlled Pilot Feasibility Trial Physical Therapy ·Monica Busse, Lori Quinn, Cheney Drew, Mark Kelson, Rob Trubey, Kirsten McEwan, Carys Jones, Julia Townson, Helen Dawes, Rhiannon Tudor Edwards, Anne Rosser, Kerenza Hood	2017	27
7	Development and Delivery of a Physical Activity Intervention for People With Huntington Disease Journal of Neurologic Physical Therapy ·Lori Quinn, Rob Trubey, Nina Gobat, Helen Dawes, Rhiannon Tudor Edwards, Carys Jones, Julia Townson, Cheney Drew, Mark Kelson, Vincent Poile, Anne Rosser, Kerenza Hood, Monica Busse	2016	21
8	Next Generation Sequencing in the Clinical Domain: Clinical Advantages, Practical, and Ethical Challenges Advances in protein chemistry and structural biology ·Rose Thompson, Cheney Drew, Rhys H. Thomas	2012	20
9	Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident–intruder paradigm in rats European Neuropsychopharmacology ·Simon Trent, Cheney Drew, Paul J. Mitchell, Sarah Bailey	2009	17
10	Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's Disease Journal of Huntington s Disease ·Simon J. Bulley, Cheney Drew, A. Jennifer Morton	2012	16
11	Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder Brain ·Anne Rosser, Monica Busse, William Gray, Romina Aron Badin, Anselme L. Perrier, Vicki Wheelock, Emanuele Cozzi, Unai Perpiñá Martin, Cristina Salado-Manzano, Laura Mills, Cheney Drew, Steven A. Goldman, Josep M. Canals, Leslie M. Thompson	2022	16
12	A systematic review on adherence to continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) in individuals with mild cognitive impairment and Alzheimer's disease dementia Sleep Medicine Reviews ·Cerys Oliver, Haoxuan Li, Bijetri Biswas, David Woodstoke, Jonathan Blackman, Anneka F Butters, Cheney Drew, Victoria Grace Gabb, Sam Harding, Camilla M. Hoyos, Adrian Kendrick, Sarah Rudd, Nicholas Turner, Elizabeth Coulthard	2023	12
13	A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD) Pilot and Feasibility Studies ·Emma Yhnell, Hannah Furby, Rachel Lowe, Lucy Brookes‐Howell, Cheney Drew, Rebecca Playle, Gareth Watson, Claudia Metzler‐Baddeley, Anne Rosser, Monica Busse	2020	12
14	Ethnicity can predict GLRA1 genotypes in hyperekplexia Journal of Neurology Neurosurgery & Psychiatry ·Rhys H. Thomas, Cheney Drew, S. E. Wood, Chrissy L. Hammond, Seo‐Kyung Chung, Mark I. Rees	2014	8
15	Physical Activity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease Physical Therapy ·Cheney Drew, Lori Quinn, Katy Hamana, Rhys Williams‐Thomas, Lucy Marsh, Polyxeni Dimitropoulou, Rebecca Playle, Beth Ann Griffin, Mark Kelson, Robin Schubert, Lisa M. Muratori, Ralf Reilmann, Anne Rosser, Monica Busse	2019	8
16	Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington’s disease Brain Communications ·Cheney Drew, Feras Sharouf, Elizabeth Randell, Lucy Brookes‐Howell, Kim Smallman, Bernadette Sewell, Astrid Burrell, Nigel Kirby, Laura Mills, Sophie V. Precious, Philip Pallmann, David Gillespie, Kerenza Hood, Monica Busse, William Gray, Anne Rosser	2021	8
17	Monitoring and Managing Lifestyle Behaviors Using Wearable Activity Trackers: Mixed Methods Study of Views From the Huntington Disease Community JMIR Formative Research ·Philippa Morgan-Jones, Annabel Jones, Monica Busse, Laura Mills, Philip Pallmann, Cheney Drew, Astri Arnesen, Fiona Wood	2022	6
18	Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study Pilot and Feasibility Studies ·Emma Yhnell, Hannah Furby, Rachel Breen, Lucy Brookes‐Howell, Cheney Drew, Rebecca Playle, Gareth Watson, Claudia Metzler‐Baddeley, Anne Rosser, Monica Busse	2018	6
19	Integrating technology into complex intervention trial processes: a case study Trials ·Cheney Drew, Vincent Poile, Rob Trubey, Gareth Watson, Mark Kelson, Julia Townson, Anne Rosser, Kerenza Hood, Lori Quinn, Monica Busse	2016	4
20	HD-DRUM, a Tablet-Based Drumming Training App Intervention for People With Huntington Disease: App Development Study JMIR Formative Research ·Claudia Metzler‐Baddeley, Monica Busse, Cheney Drew, Philip Pallmann, Jaime Cantera, Vasileios Ioakeimidis, Anne Rosser	2023	3

About Cheney Drew

Cheney Drew is a scholar working on Cellular and Molecular Neuroscience, Neurology, Behavioral Neuroscience, Neurology and Sensory Systems, having authored 30 papers that have together received 442 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (20 papers), Neurological disorders and treatments (8 papers), Mitochondrial Function and Pathology (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Pluripotent Stem Cells Research (3 papers), Neurology and Historical Studies (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (234 citations), Neurology (115 citations), Behavioral Neuroscience (13 citations), Psychiatry and Mental health (52 citations) and Neurology (25 citations). Cheney Drew has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include A. Jennifer Morton, Patrick N. Pallier, Rhys H. Thomas, Monica Busse, Anne Rosser, Dervila Glynn, Kerstin Reim, Nils Brose, Lori Quinn and Kerenza Hood. Their work appears in journals such as Human Molecular Genetics, Brain, Journal of Neurology Neurosurgery & Psychiatry, Physical Therapy and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact